Marini Francesca, Giusti Francesca, Weiss Blandine, Ovize Michel, Benvenga Salvatore, Cetani Filomena, Colao Annamaria, Corbetta Sabrina, Bondanelli Marta, Iacobone Maurizio, Lenzi Andrea, Mantovani Giovanna, Ruggeri Rosaria Maddalena, di Filippo Luigi, Giustina Andrea, Ali Dalal S, Khan Aliya A, Marcucci Gemma, Brandi Maria Luisa
FirmoLab, Fondazione FIRMO Onlus and Stabilimento Chimico Farmaceutico Militare, Florence, Italy.
Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
Aging Clin Exp Res. 2025 Jul 23;37(1):230. doi: 10.1007/s40520-025-03139-9.
Chronic hypoparathyroidism (HypoPT) is a rare endocrine condition, having variable etiology, characterized by low parathyroid hormone levels, leading to reduced calcium levels and increased phosphorus values in the blood. Bone health is an important clinical aspect to be considered in patients with HypoPT, whose skeleton is exposed both to the HypoPT-induced alteration of bone mass and microarchitecture, and to the natural occurrence and progression of bone mass loss due to menopause and ageing.
Investigating bone status in a cohort of Italian HypoPT patients from the HypoparaNET database.
In this cross-sectional study, we retrospectively analyzed bone status in 162 adult, and 11 children and adolescent HypoPT cases, based to their sex, age, HypoPT etiology, urinary excretion of calcium and phosphate, and serum level of 25(OH)-vitamin D.
Overall prevalence of osteoporosis in adult HypoPT patients was found to be slightly lower to that of the general population (17.3% vs 18.3%), increasing with ageing and being more frequent in postmenopausal women. Data from our HypoPT cohort confirmed that ageing and female sex are independent risk factors for osteoporosis, even among individuals with HypoPT.
Results from this study suggest the importance of a regular follow-up of bone health in HypoPT, especially in postmenopausal women and young patients with a genetic form of HypoPT.
Medical therapies aim at restoring a balanced bone turnover and preventing bone tissue loss could be indicated in HypoPT cases with reduced bone mass to grant a better bone health at any age.
慢性甲状旁腺功能减退症(HypoPT)是一种罕见的内分泌疾病,病因多样,其特征是甲状旁腺激素水平低,导致血钙水平降低和血磷值升高。骨骼健康是HypoPT患者需要考虑的一个重要临床方面,这类患者的骨骼既受到HypoPT引起的骨量和微结构改变的影响,也受到绝经和衰老导致的骨量丢失的自然发生和进展的影响。
研究来自HypoparaNET数据库的一组意大利HypoPT患者的骨骼状况。
在这项横断面研究中,我们根据162例成年以及11例儿童和青少年HypoPT病例的性别、年龄、HypoPT病因、钙和磷的尿排泄量以及25(OH)-维生素D的血清水平,对他们的骨骼状况进行了回顾性分析。
发现成年HypoPT患者骨质疏松的总体患病率略低于普通人群(17.3%对18.3%),且随年龄增长而增加,在绝经后女性中更为常见。我们HypoPT队列的数据证实,即使在HypoPT患者中,年龄和女性性别也是骨质疏松的独立危险因素。
本研究结果表明对HypoPT患者进行骨骼健康定期随访的重要性,尤其是在绝经后女性和患有遗传性HypoPT的年轻患者中。
对于骨量减少的HypoPT病例,可采用旨在恢复骨转换平衡和预防骨组织丢失的药物治疗,以在任何年龄实现更好的骨骼健康。